FDA inspection
Lonza Houston, Inc: FDA inspection ending Feb 2, 2024
FDA inspection 1239768 · No Action Indicated (NAI) · Houston, TX
Key facts
| Inspection ID | 1239768 |
|---|---|
| Firm | Lonza Houston, Inc |
| FEI number | 3013629214 |
| Address | 14905 Kirby Dr |
| City | Houston |
| State | TX |
| ZIP | 77047-2588 |
| Fiscal year | 2024 |
| Inspection end date | Feb 2, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data